Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study

Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been descri...

Full description

Saved in:
Bibliographic Details
Published inBMC infectious diseases Vol. 20; no. 1; pp. 311 - 8
Main Authors Zhao, Xin-Ying, Xu, Xuan-Xuan, Yin, Hai-Sen, Hu, Qin-Ming, Xiong, Tao, Tang, Yuan-Yan, Yang, Ai-Ying, Yu, Bao-Ping, Huang, Zhi-Ping
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 29.04.2020
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis.
AbstractList Abstract Background Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. Methods We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. Results Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. Conclusions Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis.
Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described.BACKGROUNDSince December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described.We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital.METHODSWe retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital.Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients.RESULTSOf the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients.Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis.CONCLUSIONSOverall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis.
Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis.
Background Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. Methods We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. Results Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. Conclusions Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis. Keywords: COVID-19, Disease characteristics, Mortality, Respiratory failure, Non-respiratory injury
Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis.
Background Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. Methods We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. Results Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. Conclusions Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis.
ArticleNumber 311
Audience Academic
Author Xu, Xuan-Xuan
Zhao, Xin-Ying
Tang, Yuan-Yan
Yang, Ai-Ying
Yin, Hai-Sen
Yu, Bao-Ping
Hu, Qin-Ming
Xiong, Tao
Huang, Zhi-Ping
Author_xml – sequence: 1
  givenname: Xin-Ying
  surname: Zhao
  fullname: Zhao, Xin-Ying
– sequence: 2
  givenname: Xuan-Xuan
  surname: Xu
  fullname: Xu, Xuan-Xuan
– sequence: 3
  givenname: Hai-Sen
  surname: Yin
  fullname: Yin, Hai-Sen
– sequence: 4
  givenname: Qin-Ming
  surname: Hu
  fullname: Hu, Qin-Ming
– sequence: 5
  givenname: Tao
  surname: Xiong
  fullname: Xiong, Tao
– sequence: 6
  givenname: Yuan-Yan
  surname: Tang
  fullname: Tang, Yuan-Yan
– sequence: 7
  givenname: Ai-Ying
  surname: Yang
  fullname: Yang, Ai-Ying
– sequence: 8
  givenname: Bao-Ping
  surname: Yu
  fullname: Yu, Bao-Ping
– sequence: 9
  givenname: Zhi-Ping
  surname: Huang
  fullname: Huang, Zhi-Ping
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32345226$$D View this record in MEDLINE/PubMed
BookMark eNqNk9tq3DAQhk1JaQ7tC_SiGHrTQp3qZMvORSEsbbMQSOnxUoyl8a6C19pK8m7zAn3uarNJyIZSii4k5O__5fmZOcz2Bjdglj2n5JjSunobKKtlUxBGClISSor1o-yACkkLxrnYu3fezw5DuCSEypo1T7J9zrgoGasOst-T3g5WQ5_rOXjQEb0N0eqQuy5fQrQ4xJCvbZznjNAm1867AVbWjyE3NiAEzO2QQ57-rfgxziGdPcJGfTa2aPNP3q3soPFNPpnbAU4S6jF6F5aoo11hHuJorp5mjzvoAz672Y-ybx_ef52cFecXH6eT0_NCV5zGopKtANOZRhhapiJQQIW8bA1oQoDRitXUEFKVtQHOsKElRWC8NTXWsu1afpRNt77GwaVaersAf6UcWHV94fxMgU_l96gk1lg1ZSNLJkVNJLQVGGlYyXjTtW2XvN5tvZZju0CjU1Ie-h3T3S-DnauZWylJ61o0Ihm8ujHw7ueIIaqFDRr7HgZ0Y1DpoYoTXoomoS8foJdu9EOKSjFBBGsISewdNYNUgB06l97VG1N1WjHJZSkYSdTxX6i0DC6sTi3W2XS_I3i9I0hMxF9xBmMIavrl8_-zF9932Rf3A7xL7rY7E1BvAZ36JXjslLYx9aTb5Gl7RYnaDILaDoJKg6CuB0Gtk5Q9kN66_0P0BxgvCJo
CitedBy_id crossref_primary_10_13105_wjma_v9_i3_220
crossref_primary_10_4236_ijcm_2020_1112060
crossref_primary_10_1016_j_ajem_2020_08_089
crossref_primary_10_1186_s12879_020_05383_y
crossref_primary_10_1016_j_dsx_2021_102308
crossref_primary_10_1186_s13054_020_03065_4
crossref_primary_10_1371_journal_pone_0250602
crossref_primary_10_1016_j_clineuro_2020_106183
crossref_primary_10_1186_s12933_020_01159_5
crossref_primary_10_1371_journal_pone_0243191
crossref_primary_10_1016_j_phrs_2020_105107
crossref_primary_10_1002_jmv_26166
crossref_primary_10_1016_j_semnephrol_2020_09_001
crossref_primary_10_1002_jgh3_12456
crossref_primary_10_3390_healthcare9111501
crossref_primary_10_7759_cureus_13894
crossref_primary_10_1097_MD_0000000000034320
crossref_primary_10_2807_1560_7917_ES_2021_26_10_2001134
crossref_primary_10_4103_jgid_jgid_136_20
crossref_primary_10_1016_j_clinre_2020_05_002
crossref_primary_10_3390_diseases8040041
crossref_primary_10_15360_1813_9779_2021_3_65_77
crossref_primary_10_1080_07853890_2020_1790643
crossref_primary_10_1002_rmv_2135
crossref_primary_10_3389_fcvm_2021_757799
crossref_primary_10_1016_j_nmni_2020_100822
crossref_primary_10_1016_j_hest_2023_02_001
crossref_primary_10_1371_journal_pone_0253446
crossref_primary_10_1016_j_clinimag_2020_10_035
crossref_primary_10_3389_fmed_2021_649583
crossref_primary_10_5812_pedinfect_106597
crossref_primary_10_21070_acopen_9_2024_10301
crossref_primary_10_1016_j_mayocp_2020_06_003
crossref_primary_10_1007_s00508_020_01693_y
crossref_primary_10_1007_s11239_021_02497_1
crossref_primary_10_1016_j_arcmed_2020_07_005
crossref_primary_10_1080_13813455_2020_1856141
crossref_primary_10_1002_jcla_24959
crossref_primary_10_1016_j_reth_2022_03_006
crossref_primary_10_1016_j_phymed_2022_153930
crossref_primary_10_1007_s10238_021_00715_x
crossref_primary_10_3390_tropicalmed8020084
crossref_primary_10_1155_2024_2993144
crossref_primary_10_3390_ijms21186960
crossref_primary_10_1093_tropej_fmab055
crossref_primary_10_21601_ejeph_10955
crossref_primary_10_1002_jmv_26737
crossref_primary_10_1055_s_0040_1719173
crossref_primary_10_52547_iau_32_1_64
crossref_primary_10_1016_j_nefroe_2022_11_005
crossref_primary_10_4103_jfmpc_jfmpc_1754_21
crossref_primary_10_1371_journal_pone_0249481
crossref_primary_10_31083_j_ceog_2020_05_2223
crossref_primary_10_3389_fmed_2021_588013
crossref_primary_10_1093_nutrit_nuaa126
crossref_primary_10_1136_bmjebm_2020_111536
crossref_primary_10_1002_ehf2_13061
crossref_primary_10_1136_bmjopen_2020_044640
crossref_primary_10_36290_vnl_2021_118
crossref_primary_10_18678_dtfd_776953
crossref_primary_10_1016_j_cca_2020_07_018
crossref_primary_10_1186_s40560_020_00508_6
crossref_primary_10_3389_fmed_2020_00458
crossref_primary_10_1016_j_biochi_2022_01_015
crossref_primary_10_1186_s12879_021_05915_0
crossref_primary_10_1021_acschemneuro_1c00353
crossref_primary_10_1097_MPA_0000000000001824
crossref_primary_10_1155_2022_5978314
crossref_primary_10_1038_s41598_021_82492_x
crossref_primary_10_1016_j_nefro_2021_09_002
crossref_primary_10_1016_j_bja_2020_06_044
crossref_primary_10_1002_edm2_338
crossref_primary_10_1007_s00405_021_06900_8
crossref_primary_10_1007_s00535_021_01778_z
crossref_primary_10_1177_0300060520972658
crossref_primary_10_3389_fphar_2020_570721
crossref_primary_10_1016_j_bspc_2022_104197
crossref_primary_10_1590_1980_57642021dn15_010001
crossref_primary_10_1007_s10072_020_04801_y
crossref_primary_10_1016_j_ajem_2020_10_022
crossref_primary_10_2147_SCCAA_S333800
crossref_primary_10_1111_ans_16260
crossref_primary_10_2174_0118749445311125240521103318
crossref_primary_10_1186_s44158_022_00046_7
crossref_primary_10_1002_jmv_26081
crossref_primary_10_1038_s41598_020_77698_4
crossref_primary_10_1016_j_dsx_2021_02_012
crossref_primary_10_1080_17474124_2020_1794812
crossref_primary_10_1136_bmjopen_2020_044661
crossref_primary_10_2147_CIA_S268607
crossref_primary_10_1136_bmjopen_2020_047016
crossref_primary_10_1155_2021_6650469
crossref_primary_10_1016_j_bspc_2022_104241
crossref_primary_10_1093_ofid_ofad105
crossref_primary_10_3390_life11111127
crossref_primary_10_7717_peerj_10771
crossref_primary_10_1097_MD_0000000000026283
crossref_primary_10_1007_s00467_020_04617_0
crossref_primary_10_37349_ei_2024_00126
crossref_primary_10_1002_clc_23465
crossref_primary_10_1136_gutjnl_2020_322072
crossref_primary_10_1080_10826076_2023_2168691
crossref_primary_10_2217_fmb_2022_0041
crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_105805
crossref_primary_10_21876_rcshci_v10i2_985
crossref_primary_10_3389_fphar_2021_607408
crossref_primary_10_1007_s40119_020_00189_0
crossref_primary_10_1513_AnnalsATS_202006_600FR
crossref_primary_10_34883_PI_2020_23_5_001
crossref_primary_10_1159_000512211
crossref_primary_10_1038_s41598_021_89419_6
crossref_primary_10_1136_bmjopen_2020_042090
crossref_primary_10_1186_s43066_022_00171_6
crossref_primary_10_1007_s11154_021_09630_8
crossref_primary_10_30699_jambs_29_136_302
crossref_primary_10_1016_j_rmed_2021_106668
crossref_primary_10_1007_s10620_021_07158_0
crossref_primary_10_1111_jocs_14808
crossref_primary_10_1002_hbe2_237
crossref_primary_10_1016_j_reth_2021_05_007
crossref_primary_10_1177_2040622321998860
crossref_primary_10_1002_iid3_471
crossref_primary_10_1155_2021_8863053
crossref_primary_10_17116_jnevro202112112113
crossref_primary_10_7759_cureus_13317
crossref_primary_10_1136_bmjgast_2020_000571
crossref_primary_10_22416_1382_4376_2020_30_6_51_56
crossref_primary_10_1093_ckj_sfaa160
crossref_primary_10_1016_j_chest_2020_10_054
crossref_primary_10_1016_j_phrs_2020_105250
crossref_primary_10_3748_wjg_v28_i46_6599
crossref_primary_10_1017_S0950268821000224
crossref_primary_10_1155_2021_6662476
crossref_primary_10_1093_cid_ciab493
crossref_primary_10_1111_jan_14558
crossref_primary_10_4103_TPSY_TPSY_6_22
crossref_primary_10_1016_j_cmi_2020_12_018
crossref_primary_10_5114_amsad_2022_115008
crossref_primary_10_1097_CRD_0000000000000422
crossref_primary_10_5662_wjm_v12_i5_365
crossref_primary_10_3390_ijerph17249360
crossref_primary_10_3390_jcm9123932
Cites_doi 10.1017/ice.2015.348
10.1101/2020.01.22.914952
10.1038/nature02145
10.1002/path.1570
10.1084/jem.20050828
10.1001/jama.2020.1623
10.1056/NEJMoa2001017
10.1378/chest.129.6.1441
10.1080/22221751.2020.1719902
10.1016/S0140-6736(20)30211-7
10.1002/ddr.21656
10.1001/jama.2020.1585
10.1101/2020.01.31.929042
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QL
7T2
7U9
7X7
7XB
88E
8C1
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
C1K
CCPQU
COVID
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12879-020-05010-w
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Health and Safety Science Abstracts (Full archive)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database (ProQuest)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic



MEDLINE
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2334
EndPage 8
ExternalDocumentID oai_doaj_org_article_7e8e695975274807ab6ad7d25239fbbf
PMC7188494
A627375420
32345226
10_1186_s12879_020_05010_w
Genre Journal Article
GeographicLocations China
United States--US
Hubei China
GeographicLocations_xml – name: China
– name: Hubei China
– name: United States--US
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8C1
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
IOV
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7QL
7T2
7U9
7XB
8FK
AZQEC
C1K
COVID
DWQXO
H94
K9.
M7N
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c631t-67b4adfd94d15323e4a6e35bdac00a216281d00658da32e9151ea23bd8e87bfb3
IEDL.DBID M48
ISSN 1471-2334
IngestDate Wed Aug 27 01:08:32 EDT 2025
Thu Aug 21 18:28:17 EDT 2025
Fri Jul 11 10:15:40 EDT 2025
Fri Jul 25 23:34:28 EDT 2025
Tue Jun 17 21:35:07 EDT 2025
Tue Jun 10 20:33:17 EDT 2025
Fri Jun 27 04:23:29 EDT 2025
Fri Jun 27 04:05:30 EDT 2025
Thu Jan 02 22:59:26 EST 2025
Thu Apr 24 23:04:03 EDT 2025
Tue Jul 01 01:57:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
Non-respiratory injury
Respiratory failure
Disease characteristics
Mortality
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c631t-67b4adfd94d15323e4a6e35bdac00a216281d00658da32e9151ea23bd8e87bfb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12879-020-05010-w
PMID 32345226
PQID 2404290096
PQPubID 42582
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_7e8e695975274807ab6ad7d25239fbbf
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7188494
proquest_miscellaneous_2396303549
proquest_journals_2404290096
gale_infotracmisc_A627375420
gale_infotracacademiconefile_A627375420
gale_incontextgauss_ISR_A627375420
gale_incontextgauss_IOV_A627375420
pubmed_primary_32345226
crossref_citationtrail_10_1186_s12879_020_05010_w
crossref_primary_10_1186_s12879_020_05010_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-04-29
PublicationDateYYYYMMDD 2020-04-29
PublicationDate_xml – month: 04
  year: 2020
  text: 2020-04-29
  day: 29
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC infectious diseases
PublicationTitleAlternate BMC Infect Dis
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References JF Chan (5010_CR10) 2020; 9
5010_CR13
J Gu (5010_CR1) 2005; 202
5010_CR12
N Chen (5010_CR4) 2020; 395
5010_CR3
W Li (5010_CR11) 2003; 426
N Zhu (5010_CR14) 2020; 382
RC Chen (5010_CR15) 2006; 129
5010_CR9
5010_CR7
5010_CR5
ADT Force (5010_CR6) 2012; 307
TW Auyeung (5010_CR16) 2005; 51
I Hamming (5010_CR8) 2004; 203
K Bedell (5010_CR2) 2016; 37
References_xml – volume: 307
  start-page: 2526
  issue: 23
  year: 2012
  ident: 5010_CR6
  publication-title: Jama
– ident: 5010_CR13
– volume: 37
  start-page: 598
  issue: 5
  year: 2016
  ident: 5010_CR2
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1017/ice.2015.348
– ident: 5010_CR9
  doi: 10.1101/2020.01.22.914952
– volume: 426
  start-page: 450
  issue: 6965
  year: 2003
  ident: 5010_CR11
  publication-title: Nature
  doi: 10.1038/nature02145
– volume: 203
  start-page: 631
  issue: 2
  year: 2004
  ident: 5010_CR8
  publication-title: J Pathol
  doi: 10.1002/path.1570
– volume: 202
  start-page: 415
  issue: 3
  year: 2005
  ident: 5010_CR1
  publication-title: J Exp Med
  doi: 10.1084/jem.20050828
– ident: 5010_CR3
  doi: 10.1001/jama.2020.1623
– volume: 382
  start-page: 727
  issue: 8
  year: 2020
  ident: 5010_CR14
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2001017
– volume: 129
  start-page: 1441
  issue: 6
  year: 2006
  ident: 5010_CR15
  publication-title: Chest
  doi: 10.1378/chest.129.6.1441
– volume: 9
  start-page: 221
  issue: 1
  year: 2020
  ident: 5010_CR10
  publication-title: Emerg Microbes Infect
  doi: 10.1080/22221751.2020.1719902
– volume: 395
  start-page: 507
  issue: 10223
  year: 2020
  ident: 5010_CR4
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30211-7
– ident: 5010_CR12
  doi: 10.1002/ddr.21656
– volume: 51
  start-page: 98
  issue: 2
  year: 2005
  ident: 5010_CR16
  publication-title: J Inf Secur
– ident: 5010_CR5
  doi: 10.1001/jama.2020.1585
– ident: 5010_CR7
  doi: 10.1101/2020.01.31.929042
SSID ssj0017829
Score 2.6078532
Snippet Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of...
Background Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and...
Abstract Background Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 311
SubjectTerms Adult
Aspartate
Aspartate aminotransferase
Betacoronavirus
Care and treatment
Chest
China - epidemiology
Chronic diseases
Chronic illnesses
Computed tomography
Coronaviridae
Coronavirus infections
Coronavirus Infections - complications
Coronavirus Infections - diagnostic imaging
Coronavirus Infections - epidemiology
Coronavirus Infections - therapy
Coronaviruses
Cough
Cough - etiology
COVID-19
Creatine
Creatine kinase
Creatinine
Diagnostic imaging
Diarrhea
Diarrhea - etiology
Disease characteristics
Disease Outbreaks
Fatalities
Fatigue - etiology
Female
Fever
Fever - etiology
Gastrointestinal tract
Health aspects
Humans
Infectious diseases
Injuries
Kidneys
Kinases
Laboratory tests
Male
Medical imaging
Middle Aged
Mortality
Non-respiratory injury
Pandemics
Patients
Pneumonia, Viral - complications
Pneumonia, Viral - diagnostic imaging
Pneumonia, Viral - epidemiology
Pneumonia, Viral - therapy
Polymerase chain reaction
Respiratory failure
Respiratory function
Retrospective Studies
SARS-CoV-2
Tomography, X-Ray Computed
Viral diseases
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yD-KL-O3qKVEEH7Rcm68mvp3isQqnop7eW0ia1Fs4Wtluvf_Av9tJmi4bRH3xbWkm0J2ZzPymSX6D0BNwGi4NbQvmDSmYI7KwlMnCCCg3JOdOVeHu8PE7sTxhb0_56U6rr3AmbKIHnhR3UHvphQLYy6F-kmVtrDCudgQKKNVa24boCzlvLqbS_gHkPTVfkZHiYIAoXKsilEolD9u_F1kaimz9v8fknaSUH5jcyUBH19DVBB3x4fTK19El391Al4_T5vhN9DNxfJ7jJmdhxn2LE3_qgMOHVwz5WOEmkBeYH6v1OOC0T4NXHTa467vi63hm4DdAyjB7OVq_wh_i54fGP8ex6_YLEF37zbqfb2viyFV7C50cvf78almkNgtFI2i1KURtmXGtU8xB-CPUMyM85daZpiwNqQQBTBuhijOUeAUYAexKrZNe1ra19DbagxfzdxG2vCHWeasoIDNKaisk945VBlCYd1IuUDVrXTeJgzy0wjjXsRaRQk-W0mApHS2lLxbo2XbO94mB46_SL4Mxt5KBPTs-AJ_Syaf0v3xqgR4HV9CBH6MLB3C-mXEY9Jv3X_ShALwXugaXfxL69DETepqE2h7-aGPSpQdQV-DdyiT3M0lY5U0-PLulTlFm0IDGAE6EKnSBHm2Hw8xwcq7z_QgyFEJsSTlTC3Rn8uKtcsDYgVAfZteZf2fay0e61VnkIAdII5li9_6Huu-jKyQuTVYQtY_2NuvRPwCot7EP46r-BT4cTu4
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgLKu-lBRmExAGiJrbj2FxQQVQLUgEBhb1Zduy0K1VJ2WzoP-B3M-P1Lo0QvUXxWEo845lv_PiGkGdgNKWyvMlEsCwTnqnMcaEyKyHdUGXpdYF3hw8_yumR-DArZ2nBrU_HKtc-MTpq39W4Rr4HkQdcJyLu12c_M6wahburqYTGVXINqcvQqqvZJuEqIPrp9UUZJfd68MWVzjBhykvcBD4fBaPI2f-vZ74QmsbHJi_EoYNtcjMBSLq_0vgtciW0t8n1w7RFfof8Tkyfp7QeczHTrqGJRbWnuPxKISprWiOFgf01Xww9Tbs1dN5SS9uuzX4MJxaeAVhi7-ngwpx-josQdXhJY-3tVyC6CMtFt76zSSNj7V1ydPDu29tplootZLXkxTKTlRPWN14LD06Q8SCsDLx03tZ5blkhGSDbCFi85SxoQAqgXe68CqpyjeP3yBZ8WHhAqCtr5nxwmgM-46xyUpXBi8ICFgteqQkp1qNu6sREjgUxTk3MSJQ0K00Z0JSJmjLnE_Ji0-dsxcNxqfQbVOZGEjm044tucWzSlDRVUEGC0VQlZOYqr6yT1leeQWquG-eaCXmKpmCQJaPFYzjHduh78_7Td7MvAfVh7eD8f0Jfv4yEniehpoMfrW26-gDDhexbI8ndkSTM9XrcvDZLk3xNb_7OjAl5smnGnnh-rg3dADIcHG3OS6En5P7KijeDA8pGWn3oXY3sezR645Z2fhKZyAHYKKHFw8s_a4fcYHHSiYzpXbK1XAzhEUC5pXsc5-sfvttGeg
  priority: 102
  providerName: ProQuest
Title Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study
URI https://www.ncbi.nlm.nih.gov/pubmed/32345226
https://www.proquest.com/docview/2404290096
https://www.proquest.com/docview/2396303549
https://pubmed.ncbi.nlm.nih.gov/PMC7188494
https://doaj.org/article/7e8e695975274807ab6ad7d25239fbbf
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLZ2kRAviDuFURmExAMEkthxbCSE1mnTQOqYCoVqL5YdO1ulKoGkYfAH-N0cu0lZxOCJl6iqj6X2XHy-Y8ffQegJOE3CFckDalUcUBPzQBPKA8Wg3OBJYkTk7g6Pj9jhlL6bJbMN1LU7ahVYX1rauX5S02rx4vvXH28g4F_7gOfsZQ1rbCoCVwiFiTvcPd9E25CZUtfRYEx_nypANhTdxZlL5_WSk-fw_3OlvpCq-q9RXshLB9fRtRZQ4t2VB9xAG7a4ia6M2yPzW-hny_y5wFmfmxmXOW5ZVWvstmMxZGmBM0dpoL7Nq6bG7ekNnhdY4aIsgs_NmYLPADTd7MNG2zk-9psSmX2OfS_uVyBa2WVVdnc4sWewvY2mB_sf9w6DtvlCkDESLQOWaqpMbgQ1sCjGxFLFLEm0UVkYqjhiMSBdD2CMIrEVgBzA2kQbbnmqc03uoC34YfYewjrJYm2sFgTwGolTzXhiDY0UYDNrOB-gqNO6zFpmctcgYyF9hcKZXFlKgqWkt5Q8H6Bn6zlfVrwc_5QeOWOuJR2ntv-irE5lG6IytdwyAQVWApU6D1OlmTKpiaFUF7nW-QA9dq4gHWtG4V7LOVVNXcu37z_JXQYo0PUSDv8m9GHSE3raCuUl_NFMtVchQF2OjasnudOThNjP-sOdW8oudCRgNAAZrjYdoEfrYTfTvU9X2LIBGQILb0gSKgbo7sqL18oBYzuafZid9vy7p73-SDE_88zkAHQ4FfT-_1D3A3Q19qFJg1jsoK1l1diHAACXeog201kKT74XDdH2aP_oeDL0mylDH-_wnIxOfgE0t1w0
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkIAXxDeFAQaBeIBoje0kNhJCYzC17APENtibsWNnqzQlo2mp-Af4c_gbuXOTsgixt71V8blKfOf7sO9-R8hTEJpEGl5EwhsWCcdkZLmQkUkh3JBJ4lSMtcPbO-lgX3w4SA6WyO-2FgbTKludGBS1q3I8I18FywOqEz3uNyffI-wahberbQuNuVhs-p8zCNnq18N3wN9njG2831sfRE1XgShPeTyJ0swK4wqnhIPdzrgXJvU8sc7k_b5hccrAhQuW2RnOvAKTCJ_BrZNeZrawHP73ArkoOGxNrExfX6SUxGBtVVuYI9PVGnR_piIM0PoJXjrPOsYv9Aj41xKcMoXdNM1Tdm_jGrnaOKx0bS5h18mSL2-QS9vNlfxN8qtBFj2meRf7mVYFbVBba4rHvRS8AEVzhEwwP0bjaU2b2yE6KqmhZVVGX6dHBn6DI4uzB1PrR_RTOPTI_Usaen2_AtKxn4yrtkaUBoTcW2T_XNhwmyzDi_m7hNokZ9Z5qzj4g5xlNpWJdyI24Pt5J2WPxO2q67xBPscGHMc6REAy1XNOaeCUDpzSsx55sZhzMsf9OJP6LTJzQYmY3eFBNT7UjQrQmZc-VRDAJSzDQn5jU-MyxxLGVWFt0SNPUBQ0onKUmPZzaKZ1rYcfv-i1FLxM7FXc_x_R7ucO0fOGqKjgQ3PTlFrAciHaV4dypUMJuiXvDrdiqRvdVuu_O7FHHi-GcSbm65W-mgINB8Xe54lQPXJnLsWLxQFmI4w_zM468t1Zve5IOToKyOfgSEmhxL2zX-sRuTzY297SW8OdzfvkCgsbUERMrZDlyXjqH4AbObEPw96l5Nt5K4s_LWmDcw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+characteristics+of+patients+with+2019+coronavirus+disease+in+a+non-Wuhan+area+of+Hubei+Province%2C+China%3A+a+retrospective+study&rft.jtitle=BMC+infectious+diseases&rft.au=Xin-Ying+Zhao&rft.au=Xuan-Xuan+Xu&rft.au=Hai-Sen+Yin&rft.au=Qin-Ming+Hu&rft.date=2020-04-29&rft.pub=BMC&rft.eissn=1471-2334&rft.volume=20&rft.issue=1&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1186%2Fs12879-020-05010-w&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_7e8e695975274807ab6ad7d25239fbbf
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon